Further experiments should determine whether long term cytostasis induced by PI3K/mTOR inhibition finally leads to cell death [51], or can be used to chronify the malignancy [7], both potentially interesting therapeutic avenues to explore in GBM treatment, in particular considering the anti-invasive effect of PI-103 discussed further below. The gene discussed is MTOR; the disease is glioblastoma.